Glaucoma is a leading cause of irreversible blindness worldwide, and Vancouver's ageing population faces a significant and growing burden of open-angle glaucoma requiring long-term intraocular pressure (IOP) management. Lumigan — containing Bimatoprost 0.01% — is one of the most effective prostaglandin analogue eye drops for reducing IOP, and generic Bimatoprost 0.01% from Unnati Pharmax provides the same therapeutic benefit at a reduced cost.
Bimatoprost 0.01% reduces IOP by increasing the outflow of aqueous humour through both the trabecular meshwork and the uveoscleral pathway — its dual mechanism of action makes it one of the most potent IOP-lowering agents available, producing average reductions of 28-33% from baseline. It is administered as one drop in the affected eye(s) once daily in the evening, with the evening dosing schedule found to produce better IOP reduction than morning application in clinical studies.
Vancouver ophthalmologists at VGH Eye Care Centre and private ophthalmology clinics manage hundreds of glaucoma patients who require consistent, long-term Bimatoprost therapy. For patients on fixed incomes or those not fully covered by BC PharmaCare for prostaglandin analogues, generic Bimatoprost 0.01% from India offers meaningful cost savings without compromising the IOP reduction that protects their vision.
Unnati Pharmax supplies Lumigan Bimatoprost 0.01% eye drops to ophthalmology clinics, pharmacies, and glaucoma patients in Vancouver and across Canada. Contact medshopy.com or WhatsApp +91 82650 41513.
